3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
4
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
7
Pancreatic Neoplasms
3
Stomach Neoplasms
2
Recurrence
2
Neoplasms
2
Nasopharyngeal Carcinoma
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Rectal Neoplasms
1
Pseudomyxoma Peritonei
1
Peritoneal Neoplasms
1
Neutropenia
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Muscle Neoplasms
1
Mesothelioma
1
Locally Advanced Pancreatic Adenocarcinoma
1
Liver Neoplasms
1
Keratosis, Actinic
1
Gallbladder Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Colorectal Cancer Metastatic
1
Colonic Neoplasms
1
Chronic Pain
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Breast Cancer Organoids
1
Interventions
Itraconazole
2
ziprasidone
1
pegylated granulocyte colony-stimulating factor
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Tobramycin
1
Spironolactone
1
Sevelamer
1
Rocuronium
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Oxaliplatin
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Lurasidone Hydrochloride
1
Leucovorin
1
Labetalol
1
Haloperidol
1
Fosfomycin
1
Fluorouracil
1
Clozapine
1
Ciprofloxacin
1
Cidofovir
1
Cefepime
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Neutropenia
×
Fluorouracil
×
Clear all
NCT02135887
2020-12-22
MB-6
Microbio Co Ltd
Unknown
184 enrolled